Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.
- clinical laboratory techniques
- Clostridium difficile
- nucleic acid amplification techniques
ASJC Scopus subject areas
- Infectious Diseases
- Microbiology (medical)